Principal Securities Inc. Has $2.60 Million Position in Sanofi (NASDAQ:SNY)

Principal Securities Inc. increased its position in shares of Sanofi (NASDAQ:SNY) by 6.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 45,050 shares of the company’s stock after acquiring an additional 2,555 shares during the period. Principal Securities Inc.’s holdings in Sanofi were worth $2,596,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. US Bancorp DE grew its position in Sanofi by 8.6% in the third quarter. US Bancorp DE now owns 111,405 shares of the company’s stock valued at $6,420,000 after acquiring an additional 8,813 shares during the last quarter. Nikulski Financial Inc. acquired a new stake in shares of Sanofi in the 3rd quarter valued at approximately $218,000. Financial Advocates Investment Management grew its holdings in shares of Sanofi by 3.4% during the 3rd quarter. Financial Advocates Investment Management now owns 6,327 shares of the company’s stock valued at $365,000 after purchasing an additional 206 shares during the last quarter. Pinnacle Associates Ltd. increased its position in Sanofi by 7.1% during the 3rd quarter. Pinnacle Associates Ltd. now owns 12,077 shares of the company’s stock worth $696,000 after purchasing an additional 798 shares in the last quarter. Finally, First Trust Direct Indexing L.P. lifted its stake in Sanofi by 3.1% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 26,359 shares of the company’s stock valued at $1,519,000 after purchasing an additional 791 shares during the last quarter. 10.04% of the stock is owned by institutional investors.

Sanofi Price Performance

SNY stock opened at $53.27 on Friday. The company has a market capitalization of $135.19 billion, a P/E ratio of 27.18, a PEG ratio of 1.35 and a beta of 0.61. The company has a fifty day moving average price of $55.92 and a 200-day moving average price of $52.00. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 1.00. Sanofi has a 52-week low of $45.00 and a 52-week high of $58.97.

Sanofi (NASDAQ:SNY) last announced its earnings results on Friday, October 25th. The company reported $1.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $1.35. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. The business had revenue of $13.44 billion during the quarter, compared to analyst estimates of $16.59 billion. During the same period last year, the company earned $2.55 EPS. Sanofi’s revenue for the quarter was up 12.3% compared to the same quarter last year. As a group, equities analysts expect that Sanofi will post 4.27 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Argus boosted their target price on shares of Sanofi from $55.00 to $60.00 and gave the stock a “buy” rating in a research note on Friday, July 26th. Citigroup upgraded Sanofi to a “strong-buy” rating in a research report on Tuesday, September 17th. Finally, StockNews.com upgraded Sanofi from a “buy” rating to a “strong-buy” rating in a research report on Wednesday. Two research analysts have rated the stock with a hold rating, one has given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Sanofi currently has a consensus rating of “Buy” and a consensus price target of $57.50.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.